BIOMAT Database Logo BIOMAT Database Logo

Focal and diffuse membranoproliferative glomerulonephritis in children. 1988

N Yoshikawa, and S Yoshiara, and K Yoshiya, and T Matsuo, and S Matsuyama, and S Okada
Department of Pediatrics, Kobe University Hospital, Japan.

Characteristic deposition of C3 has been reported in type I membranoproliferative glomerulonephritis (MPGN). Immunofluorescence microscopy shows diffuse granular deposition of C3 along the majority of capillary loops with lobular pattern. To determine the specificity of this immunofluorescence finding which might aid in distinction between type 1 MPGN, particularly focal MPGN, and the other glomerulopathies, 530 renal biopsies from 437 children were studied retrospectively. Nineteen patients showed diffuse granular deposits of C3 along the capillary walls with lobular distribution. Three patients had lupus nephritis. Nine patients showed the light microscopic changes of diffuse type I MPGN with the characteristic double-walled capillaries. Six patients showed the changes of focal MPGN, and 1 had diffuse mesangial proliferation but without double contours, and they were regarded as examples of a mild or early form of MPGN. A similar deposition of C3 was not seen in the 418 patients with other conditions. We concluded that diffuse granular deposits of C3 along the capillary walls with a lobular distribution appear to be confined to type I MPGN and lupus nephritis and are seen in all patients with diffuse and focal type I MPGN.

UI MeSH Term Description Entries
D007678 Kidney Glomerulus A cluster of convoluted capillaries beginning at each nephric tubule in the kidney and held together by connective tissue. Glomerulus, Kidney
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

N Yoshikawa, and S Yoshiara, and K Yoshiya, and T Matsuo, and S Matsuyama, and S Okada
Focal segmental membranoproliferative glomerulonephritis in children.
October 2003, Pediatric nephrology (Berlin, Germany),
N Yoshikawa, and S Yoshiara, and K Yoshiya, and T Matsuo, and S Matsuyama, and S Okada
[Membranoproliferative glomerulonephritis in children].
July 1985, Ceskoslovenska pediatrie,
N Yoshikawa, and S Yoshiara, and K Yoshiya, and T Matsuo, and S Matsuyama, and S Okada
A patient with membranoproliferative glomerulonephritis diagnosed by the third biopsy via endocapillary proliferative glomerulonephritis and focal membranoproliferative glomerulonephritis.
June 2003, Clinical and experimental nephrology,
N Yoshikawa, and S Yoshiara, and K Yoshiya, and T Matsuo, and S Matsuyama, and S Okada
Membranoproliferative glomerulonephritis characterized by focal, segmental proliferative lesions.
July 1982, Clinical nephrology,
N Yoshikawa, and S Yoshiara, and K Yoshiya, and T Matsuo, and S Matsuyama, and S Okada
Idiopathic membranoproliferative glomerulonephritis in Japanese children.
June 1995, Pediatric nephrology (Berlin, Germany),
N Yoshikawa, and S Yoshiara, and K Yoshiya, and T Matsuo, and S Matsuyama, and S Okada
The composition of glomerulosclerosis. I. Studies in focal sclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis.
August 1984, Laboratory investigation; a journal of technical methods and pathology,
N Yoshikawa, and S Yoshiara, and K Yoshiya, and T Matsuo, and S Matsuyama, and S Okada
Prednisone therapy of membranoproliferative glomerulonephritis in children.
November 1985, The Journal of pediatrics,
N Yoshikawa, and S Yoshiara, and K Yoshiya, and T Matsuo, and S Matsuyama, and S Okada
Membranoproliferative glomerulonephritis and C3 glomerulonephritis: frequency, clinical features, and outcome in children.
April 2015, Nephrology (Carlton, Vic.),
N Yoshikawa, and S Yoshiara, and K Yoshiya, and T Matsuo, and S Matsuyama, and S Okada
[Membranoproliferative glomerulonephritis].
January 2010, Nihon Jinzo Gakkai shi,
N Yoshikawa, and S Yoshiara, and K Yoshiya, and T Matsuo, and S Matsuyama, and S Okada
[Membranoproliferative glomerulonephritis].
September 1989, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Copied contents to your clipboard!